or Try an Advanced Search...

    Technical Analysis for VRDN - Viridian Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 22.50 6.84% 1.44
    VRDN closed up 6.84 percent on Thursday, September 19, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical VRDN trend table...
    Date Alert Name Type % Chg
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    180 Bullish Setup Bullish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Outside Day Range Expansion 6.84%
    Wide Bands Range Expansion 6.84%
    Older End-of-Day Signals for VRDN ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 4 hours ago
    Possible Inside Day about 4 hours ago
    60 Minute Opening Range Breakout about 7 hours ago
    Up 5% about 7 hours ago
    Gap Up Partially Closed about 8 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    VRDN Chart by TradingView
    Basic chart:

    Profile

    Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado, with research and development operations in Waltham, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Biotechnology Biology Monoclonal Antibody Thyroid Eye Disease

    Is VRDN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 12 Viridian Therapeutics slides on pricing $225M securities offering
    Sep 12 Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock
    Sep 10 Viridian: Active TED Data Signifies Next Round Of Positive Data On The Way
    Sep 10 Viridian Therapeutics announces proposed underwritten offering
    Sep 10 Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
    Sep 10 Biggest stock movers today: ORCL, RBRK, VRDN, and more
    Sep 10 Viridian posts initial late-stage trial data for lead asset
    Sep 10 Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease
    Sep 9 Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024
    Sep 5 Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    See more VRDN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 24.18
    52 Week Low 10.925
    Average Volume 1,560,622
    200-Day Moving Average 16.62
    50-Day Moving Average 16.08
    20-Day Moving Average 17.17
    10-Day Moving Average 19.59
    Average True Range 1.58
    RSI (14) 75.00
    ADX 34.77
    +DI 34.89
    -DI 7.99
    Chandelier Exit (Long, 3 ATRs) 19.07
    Chandelier Exit (Short, 3 ATRs) 17.93
    Upper Bollinger Bands 23.56
    Lower Bollinger Band 10.79
    Percent B (%b) 0.92
    BandWidth 74.36
    MACD Line 1.82
    MACD Signal Line 1.15
    MACD Histogram 0.6676
    Fundamentals Value
    Market Cap 1.34 Billion
    Num Shares 59.7 Million
    EPS -5.14
    Price-to-Earnings (P/E) Ratio -4.38
    Price-to-Sales 3322.96
    Price-to-Book 7.22
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 23.97
    Resistance 3 (R3) 23.82 23.17 23.73
    Resistance 2 (R2) 23.17 22.80 23.25 23.64
    Resistance 1 (R1) 22.84 22.57 23.01 22.99 23.56
    Pivot Point 22.19 22.19 22.28 22.27 22.19
    Support 1 (S1) 21.86 21.82 22.03 22.01 21.44
    Support 2 (S2) 21.21 21.59 21.29 21.36
    Support 3 (S3) 20.88 21.21 21.28
    Support 4 (S4) 21.03